5 completed, 2 terminated. 7 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 5, Terminated 2 |
| Phase 2 | 2 | Completed 2 |
Follow terameprocol: new trials by email Literature Review of terameprocol trials Research Report on terameprocol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Terameprocol in Treating Patients With Recurrent High Grade Glioma Terameprocol, Pharmacological Study - High Grade Glioma (III or IV) | Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 20 | 2018-05-03 | 2023-10-06 |
| Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia Terameprocol (EM-1421) - Leukemias, Acute Myeloid Leukemia (AML) | Phase 1 | Terminated | Erimos Pharmaceuticals | 16 | 2007-08-01 | 2016-02-23 |
| A Phase 1 Continuous Intravenous Infusion Study of Terameprocol (EM-1421) in Subjects With Refractory Solid Tumors Terameprocol (EM-1421) - Refractory Solid Tumors, Lymphoma | Phase 1 | Terminated | Erimos Pharmaceuticals | 21 | 2007-05-01 | 2016-02-23 |
| Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma terameprocol, pharmacological study - Brain and Central Nervous System Tumors | Phase 1 / Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 35 | 2007-01-01 | 2019-03-06 |
| Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors EM-1421 - Cancer | Phase 1 | Completed | Erimos Pharmaceuticals | 30 | 2005-12-01 | 2008-01-24 |
| A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia EM-1421 - Cervical Intraepithelial Neoplasia | Phase 1 / Phase 2 | Completed | Erimos Pharmaceuticals | 8 | 2004-11-01 | 2016-02-23 |
| Study of Intralesional Injection of M4N in Patients With Refractory Malignant Tumors of the Head and Neck M4N - Head and Neck Neoplasms | Phase 1 | Completed | Erimos Pharmaceuticals | 9 | 2003-01-01 | 2016-02-23 |
Astrocytoma (1) · Brain Neoplasms (1) · Central Nervous System Neoplasms (1) · Glioblastoma (1) · Glioma (1) · Gliosarcoma (1) · Head and Neck Neoplasms (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Chronic (1) · Lymphoma (1) · Myelodysplastic Syndromes (1) · Neoplasms (1)
Erimos Pharmaceuticals (5) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2)
United States (7)
Neil Frazer, MB, ChB (2) · Manmeet Ahluwalia, MD (1) · Neil Frazer, MB (1) · Stuart A. Grossman, MD (1)
U01CA062475 (1), UM1CA137443 (1)